HPST webinar: Agilent HPLC columns for biopharmaceutical applications – basic overview of portfolio. part II.

One of the fastest growing pharmaceutical industries is the development of biotherapeutics. Their production is one of the most strictly regulated processes, which ensures the creation of a highly efficient and functional product. With the help of risk analysis, the identification of critical variables (CQA – Critical Quality Attributes) influencing the final quality of the product is performed.

Agilent offers a variety of chromatographic LC columns for monitoring and identifying critical variables in the pharmaceutical biomass industry. A lecture (February 24, 2022) by our product specialist Robert Kukula is focused on an overview of the portfolio of bio HPLC columns, to which we cordially invite you.